Cargando…

HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis

INTRODUCTION: Molecular alterations leading progression of asymptomatic CLL-like high-count monoclonal B lymphocytosis (hiMBL) to chronic lymphocytic leukemia (CLL) remain poorly understood. Recently, genome-wide association studies have found 6p21.3, where the human leukocyte antigen (HLA) system i...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Álvarez, María, Alcoceba, Miguel, López-Parra, Miriam, Puig, Noemí, Antón, Alicia, Balanzategui, Ana, Prieto-Conde, Isabel, Jiménez, Cristina, Sarasquete, María E., Chillón, M. Carmen, Gutiérrez, María Laura, Corral, Rocío, Alonso, José María, Queizán, José Antonio, Vidán, Julia, Pardal, Emilia, Peñarrubia, María Jesús, Bastida, José M., García-Sanz, Ramón, Marín, Luis, González, Marcos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332061/ https://www.ncbi.nlm.nih.gov/pubmed/28249016 http://dx.doi.org/10.1371/journal.pone.0172978

Ejemplares similares

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas
por: García-Álvarez, María, et al.
Publicado: (2019)

Celebrating 20 Years of IGHV Mutation Analysis in CLL
por: Chiorazzi, Nicholas, et al.
Publicado: (2020)

From Waldenström’s macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation
por: Jiménez, C, et al.
Publicado: (2017)

Combined Patterns of IGHV Repertoire and Cytogenetic/Molecular Alterations in Monoclonal B Lymphocytosis versus Chronic Lymphocytic Leukemia
por: Henriques, Ana, et al.
Publicado: (2013)

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL
por: Parikh, Sameer A., et al.
Publicado: (2021)

Double IGHV DNA gene rearrangements in CLL: influence of mixed-mutated and -unmutated rearrangements on outcomes in CLL
por: Heyman, B, et al.
Publicado: (2016)

P606: MEASUREMENT OF INTRACLONAL DIVERSIFICATION REFINES THE PROGNOSTIC IMPACT OF IGHV MUTATIONS IN CLL
por: Vit, Filippo, et al.
Publicado: (2023)

Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative
por: Bosch, Francesc, et al.
Publicado: (2021)

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
por: Medina, Alejandro, et al.
Publicado: (2020)

Flow cytometry as a fast, cost-effective tool to assess IGHV mutational status in CLL
por: Couillez, Guillaume, et al.
Publicado: (2022)

MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies
por: Alcoceba, Miguel, et al.
Publicado: (2022)

Genetic complexity impacts the clinical outcome of follicular lymphoma patients
por: García-Álvarez, María, et al.
Publicado: (2021)

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells
por: Rigoni, Micol, et al.
Publicado: (2015)

Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity
por: Sofou, Electra, et al.
Publicado: (2022)

MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL
por: Rodríguez-Vicente, Ana E, et al.
Publicado: (2015)

A Case of COVID-19–Induced Lymphocytosis in a Patient With Treatment-Naive CLL: Should It Be treated?
por: Safarpour, Damoun, et al.
Publicado: (2021)

Immnuophenotypic and Gene Expression Analysis of Monoclonal B Cell Lymphocytosis Shows Biologic Characteristics Associated With Good Prognosis CLL
por: Lanasa, Mark C., et al.
Publicado: (2011)

The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct Outcome
por: Rodríguez-Caballero, Arancha, et al.
Publicado: (2021)

Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease
por: Rose-Zerilli, M J J, et al.
Publicado: (2016)

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
por: Medina, Alejandro, et al.
Publicado: (2020)

Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status
por: Shea, Lauren K., et al.
Publicado: (2019)

Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay
por: Mimmi, Selena, et al.
Publicado: (2022)

Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level
por: García-Sanz, Ramón, et al.
Publicado: (2023)

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans
por: Kleinstern, Geffen, et al.
Publicado: (2021)

HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population
por: Montes-Cano, Marco Antonio, et al.
Publicado: (2012)

Infectious Lymphocytosis
por: McCollum, J. Kinloch
Publicado: (1949)

The Lymphocytosis of Infection
por: Wilson-Smith, T.
Publicado: (1928)

New Insights into Monoclonal B-Cell Lymphocytosis
por: Kalpadakis, Christina, et al.
Publicado: (2014)

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
por: Quijada-Álamo, Miguel, et al.
Publicado: (2020)

Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemia
por: Criado, Ignacio, et al.
Publicado: (2018)

Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition
por: Pepper, C, et al.
Publicado: (2015)

Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL
por: Bryant, Dean, et al.
Publicado: (2023)

Assessment of an Educational Intervention to Improve Healthy Life Habits in Children Living in Vulnerable Socioeconomic Conditions
por: López, María, et al.
Publicado: (2021)

PB1911: CYTOGENOMIC INTEGRATIVE ANALYSIS OF CLL/SLL PATIENTS AT DISEASE PROGRESSION.
por: García-Serra, Rocío, et al.
Publicado: (2023)

IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity
por: Avnir, Yuval, et al.
Publicado: (2016)

MHC-I Molecules Selectively Inhibit Cell-Mediated Cytotoxicity Triggered by ITAM-Coupled Activating Receptors and 2B4
por: Corral-San Miguel, Rubén, et al.
Publicado: (2014)

Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis
por: Marín-Quílez, Ana, et al.
Publicado: (2023)

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
por: Chatzikonstantinou, Thomas, et al.
Publicado: (2021)

Prevalence and Immunophenotypic Characteristics of Monoclonal B-Cell Lymphocytosis in Healthy Korean Individuals With Lymphocytosis
por: Yoo, In Young, et al.
Publicado: (2020)

Erratum: IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity
por: Avnir, Yuval, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_14eemcg639a35aq6bnq6pbsva8